Surfactant dysfunction disorder masquerading as meconium aspiration syndrome and persistent pulmonary hypertension of the newborn

BMJ Case Rep. 2021 Jan 27;14(1):e239169. doi: 10.1136/bcr-2020-239169.

Abstract

About 10% of term neonates present with respiratory distress at birth. The most common aetiologies include transient tachypnoea of the newborn, pneumonia and meconium aspiration syndrome (MAS). Hyaline membrane disease (HMD) in a term infant occurs either as primary HMD, secondary surfactant deficiency or congenital surfactant dysfunction. A detailed history supported with appropriate radiological and laboratory investigations can help a clinician reach a diagnosis. We report a case of surfactant dysfunction disorder which presented as severe MAS and persistent pulmonary hypertension of the newborn. In the infant described, the significant history of a sibling death with severe neonatal respiratory disease led us to think of diffuse developmental lung diseases especially surfactant dysfunction syndromes. Exome sequencing detected a heterozygous missense variation in exon 21 of the ATP binding cassette protein member 3 (ABCA3) gene. Based on the clinical picture supported with the exome sequencing, a diagnosis of surfactant dysfunction disorder (ABCA3 deficiency) was confirmed.

Keywords: congenital disorders; materno-fetal medicine; neonatal and paediatric intensive care; neonatal health.

Publication types

  • Case Reports

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Bronchodilator Agents / therapeutic use
  • Diagnosis, Differential
  • Fatal Outcome
  • Humans
  • Infant, Newborn
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / genetics
  • Lung Diseases, Interstitial / therapy
  • Male
  • Meconium Aspiration Syndrome / diagnosis*
  • Nitric Oxide / therapeutic use
  • Persistent Fetal Circulation Syndrome / diagnosis*
  • Pulmonary Surfactants / therapeutic use
  • Respiration, Artificial
  • Sildenafil Citrate / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • ABCA3 protein, human
  • ATP-Binding Cassette Transporters
  • Bronchodilator Agents
  • Pulmonary Surfactants
  • Vasodilator Agents
  • Nitric Oxide
  • Sildenafil Citrate

Supplementary concepts

  • Surfactant Dysfunction